Table 3:
Reader, Scanb | No.c | Total | Median (mean) | Minimum | Maximumd |
---|---|---|---|---|---|
1 | |||||
A | 56 | 243 | 2.5 (4.3) | 1.000 | 20.000 |
B | 54 | 238 | 2.0 (4.4) | 1.000 | 20.000 |
C | 61 | 362 | 3.0 (5.9) | 1.000 | 20.000 |
D | 63 | 379 | 3.0 (6.0) | 1.000 | 20.000 |
2 | |||||
A | 58 | 260 | 2.0 (4.5) | 1.000 | 20.000 |
B | 61 | 308 | 3.0 (5.0) | 1.000 | 20.000 |
C | 68 | 373 | 3.0 (5.5) | 1.000 | 20.000 |
D | 64 | 402 | 3.0 (6.3) | 1.000 | 20.000 |
3 | |||||
A | 69 | 325 | 2.0 (4.7) | 1.000 | 20.000 |
B | 67 | 358 | 3.0 (5.3) | 1.000 | 20.000 |
C | 76 | 455 | 3.0 (6.0) | 1.000 | 20.000 |
D | 79 | 490 | 3.0 (6.2) | 1.000 | 20.000 |
A higher number of enhancing lesions was detected for cumulative-versus-single dose scans (P < .001).
A, early single dose; B, delayed single dose; C, early cumulative dose; D, delayed cumulative dose.
No., number of patients with active lesions.
The number of lesions was restricted to a maximum of 20 per patient.